Tocagen (TOCA)

9.13 -0.82 (8.24%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/8/18 *Est.)

Latest Headlines

Tocagen (TOCA) Prices 3M Share Common Offering at $10/Sh December 13, 2018 5:52 AM - StreetInsider Tocagen Announces Pricing of Public Offering of Common Stock December 12, 2018 7:00 PM - PR NewsWire Tocagen (TOCA) Announces Proposed 3M Share Common Offering December 11, 2018 5:10 PM - StreetInsider Tocagen Announces Proposed Public Offering of Common Stock December 11, 2018 5:08 PM - PR NewsWire Tocagen (TOCA), NRG Oncology Announce Collaboration on Phase 2/3 Trial of Toca 511 & Toca FC in Newly Diagnosed Glioblastoma November 29, 2018 8:02 AM - StreetInsider Tocagen and NRG Oncology to Collaborate on a Phase 2/3 Trial of Toca 511 & Toca FC in Newly Diagnosed Glioblastoma November 29, 2018 8:00 AM - PR NewsWire Tocagen Appoints Lori Kunkel, M.D. as Acting Chief Medical Officer November 15, 2018 4:01 PM - PR NewsWire Tocagen Reports Third Quarter 2018 Financial and Business Results November 8, 2018 4:01 PM - PR NewsWire Tocagen to Participate in Investor Conferences in November November 7, 2018 4:01 PM - PR NewsWire Tocagen to Present Updated Data from Clinical and Preclinical Studies at Three Scientific and Medical Conferences November 6, 2018 8:00 AM - PR NewsWire Tocagen to Report Third Quarter 2018 Financial Results on Thursday, November 8 November 1, 2018 4:01 PM - PR NewsWire Factors of Influence in 2018, Key Indicators and Opportunity within Wix, Darden Restaurants, Dollar General, TOCAGEN INC, Burlington Stores, and McCormick & Company — New Research Emphasizes Eco October 22, 2018 8:55 AM - Globe NewsWire Tocagen (TOCA) Provides Update on European Regulatory Path for Toca 511 and Toca FC October 2, 2018 8:04 AM - StreetInsider Tocagen Provides Update on European Regulatory Path for Toca 511 & Toca FC October 2, 2018 8:00 AM - PR NewsWire Tocagen Presents Preliminary Data from Toca 6 Trial Supportive of Immune Activation in Patients with Advanced Solid Tumors at CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference September 30, 2018 11:57 AM - PR NewsWire Tocagen to Participate in Four Investor Conferences in October September 27, 2018 4:33 PM - PR NewsWire Tocagen Appoints Mohamed Ladha as Vice President to Establish Commercial Organization September 24, 2018 8:00 AM - PR NewsWire Tocagen Inc. (TOCA) PT Raised to $22 at B.Riley/FBR September 20, 2018 6:20 AM - StreetInsider Tocagen (TOCA) Reports Early Completion of Enrollment in Toca 5 Pivotal Phase 3 Brain Cancer Trial September 19, 2018 8:02 AM - StreetInsider Tocagen Announces Early Completion of Enrollment in Toca 5 Pivotal Phase 3 Brain Cancer Trial September 19, 2018 8:00 AM - PR NewsWire Full Article List